ES2266374T3 - Procedimiento para la deteccion de adn procariotico. - Google Patents
Procedimiento para la deteccion de adn procariotico. Download PDFInfo
- Publication number
- ES2266374T3 ES2266374T3 ES02020904T ES02020904T ES2266374T3 ES 2266374 T3 ES2266374 T3 ES 2266374T3 ES 02020904 T ES02020904 T ES 02020904T ES 02020904 T ES02020904 T ES 02020904T ES 2266374 T3 ES2266374 T3 ES 2266374T3
- Authority
- ES
- Spain
- Prior art keywords
- dna
- protein
- polypeptide
- baselineskip
- prokaryotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 70
- 238000001514 detection method Methods 0.000 title claims abstract description 39
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 65
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 60
- 229920001184 polypeptide Polymers 0.000 claims abstract description 44
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 44
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 44
- 108020004414 DNA Proteins 0.000 claims description 136
- 210000001124 body fluid Anatomy 0.000 claims description 27
- 239000010839 body fluid Substances 0.000 claims description 27
- 238000000926 separation method Methods 0.000 claims description 22
- 230000027455 binding Effects 0.000 claims description 14
- 239000011859 microparticle Substances 0.000 claims description 10
- 239000011159 matrix material Substances 0.000 claims description 8
- 239000000523 sample Substances 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 7
- 239000002299 complementary DNA Substances 0.000 claims description 6
- 238000000338 in vitro Methods 0.000 claims description 6
- 230000011987 methylation Effects 0.000 claims description 6
- 238000007069 methylation reaction Methods 0.000 claims description 6
- 101000947157 Homo sapiens CXXC-type zinc finger protein 1 Proteins 0.000 claims description 5
- 230000003321 amplification Effects 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 101150038509 TLR9 gene Proteins 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000001962 electrophoresis Methods 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 description 23
- 244000052769 pathogen Species 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 230000001717 pathogenic effect Effects 0.000 description 13
- 241000282414 Homo sapiens Species 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 238000007857 nested PCR Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 238000007399 DNA isolation Methods 0.000 description 4
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 4
- 102100033117 Toll-like receptor 9 Human genes 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102100036168 CXXC-type zinc finger protein 1 Human genes 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 2
- 230000004568 DNA-binding Effects 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- -1 agarose Chemical class 0.000 description 2
- 102000023732 binding proteins Human genes 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 238000009640 blood culture Methods 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 239000000304 virulence factor Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 244000078885 bloodborne pathogen Species 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000004794 expanded polystyrene Substances 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 230000001951 hemoperfusion Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 239000002683 reaction inhibitor Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 108010075210 streptolysin O Proteins 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02020904A EP1400589B1 (de) | 2002-09-18 | 2002-09-18 | Verfahren zum Nachweis prokaryontischer DNA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2266374T3 true ES2266374T3 (es) | 2007-03-01 |
Family
ID=31896878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES02020904T Expired - Lifetime ES2266374T3 (es) | 2002-09-18 | 2002-09-18 | Procedimiento para la deteccion de adn procariotico. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8062854B2 (https=) |
| EP (1) | EP1400589B1 (https=) |
| JP (1) | JP4447459B2 (https=) |
| KR (1) | KR20050057152A (https=) |
| CN (1) | CN1681925A (https=) |
| AT (1) | ATE335816T1 (https=) |
| AU (1) | AU2003260392A1 (https=) |
| CA (1) | CA2498951C (https=) |
| DE (1) | DE50207801D1 (https=) |
| DK (1) | DK1400589T3 (https=) |
| ES (1) | ES2266374T3 (https=) |
| WO (1) | WO2004033683A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1400589T3 (da) | 2002-09-18 | 2006-11-27 | Sirs Lab Gmbh | Fremgangsmåde til påvisning af prokaryotisk DNA |
| DE102005001889B4 (de) * | 2005-01-14 | 2012-03-29 | Sirs-Lab Gmbh | Verfahren zur Steigerung der Bindungskapazität und -effizienz eines Proteins, das nicht methylierte CPG-Motive enthaltende DNA spezifisch bindet |
| ES2384571T3 (es) * | 2004-03-05 | 2012-07-09 | Sirs-Lab Gmbh | Procedimiento para el enriquecimiento y/o la separación de ADN procariota mediante una proteína que se une específicamente a ADN que contiene motivos CpG no metilados |
| GB0413688D0 (en) * | 2004-06-18 | 2004-07-21 | Novartis Forschungsstiftung | Analysis of methylated nucleic acid |
| DE202005009490U1 (de) * | 2005-06-16 | 2006-10-19 | Sirs-Lab Gmbh | Vorrichtung zur Anreicherung/Abtrennung von nicht-methylierte CpG-Motive enthaltender DNA |
| DE102005034628B4 (de) * | 2005-07-19 | 2007-08-23 | Epigenomics Ag | Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA |
| DE102007041864B4 (de) | 2007-09-04 | 2012-05-03 | Sirs-Lab Gmbh | Verfahren zum Nachweis von Bakterien und Pilzen |
| DK3067431T3 (da) | 2010-09-15 | 2019-10-14 | Debiopharm Int Sa | Indretning omfattende blodkomponenter til at adskille målmolekyler eller partikler fra prøver |
| US8980553B2 (en) * | 2011-04-02 | 2015-03-17 | New England Biolabs, Inc. | Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides |
| US9145580B2 (en) * | 2011-04-02 | 2015-09-29 | New England Biolabs, Inc. | Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides |
| DE102012219142B4 (de) | 2012-10-19 | 2016-02-25 | Analytik Jena Ag | Verfahren zum Trennen, Erfassen oder Anreichern von unterschiedlichen DNA-Spezies |
| US12612615B2 (en) | 2019-04-26 | 2026-04-28 | Thermo Fisher Scientific Baltics, UAB | Isolated nucleic acid binding domains |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| WO1997005484A1 (en) | 1995-07-28 | 1997-02-13 | Beth Israel Deaconess Medical Center, Inc. | A method of and test kit for mutagenesis testing |
| EP1248798A2 (en) | 1999-08-18 | 2002-10-16 | Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V. | Human dna sequences |
| JP2002034565A (ja) | 2000-07-19 | 2002-02-05 | Japan Science & Technology Corp | 細菌ｄｎａを特異的に認識する受容体タンパク質 |
| DK1400589T3 (da) | 2002-09-18 | 2006-11-27 | Sirs Lab Gmbh | Fremgangsmåde til påvisning af prokaryotisk DNA |
| ES2384571T3 (es) | 2004-03-05 | 2012-07-09 | Sirs-Lab Gmbh | Procedimiento para el enriquecimiento y/o la separación de ADN procariota mediante una proteína que se une específicamente a ADN que contiene motivos CpG no metilados |
| GB0423991D0 (en) | 2004-10-29 | 2004-12-01 | Univ Edinburgh | Applications of nucleic acid fragments |
-
2002
- 2002-09-18 DK DK02020904T patent/DK1400589T3/da active
- 2002-09-18 AT AT02020904T patent/ATE335816T1/de active
- 2002-09-18 EP EP02020904A patent/EP1400589B1/de not_active Expired - Lifetime
- 2002-09-18 ES ES02020904T patent/ES2266374T3/es not_active Expired - Lifetime
- 2002-09-18 DE DE50207801T patent/DE50207801D1/de not_active Expired - Lifetime
-
2003
- 2003-08-08 WO PCT/EP2003/008825 patent/WO2004033683A1/de not_active Ceased
- 2003-08-08 AU AU2003260392A patent/AU2003260392A1/en not_active Abandoned
- 2003-08-08 CN CNA038222337A patent/CN1681925A/zh active Pending
- 2003-08-08 US US10/528,235 patent/US8062854B2/en not_active Expired - Fee Related
- 2003-08-08 JP JP2004542300A patent/JP4447459B2/ja not_active Expired - Fee Related
- 2003-08-08 CA CA2498951A patent/CA2498951C/en not_active Expired - Fee Related
- 2003-08-08 KR KR1020057003719A patent/KR20050057152A/ko not_active Ceased
-
2011
- 2011-10-05 US US13/253,661 patent/US8288115B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1400589A1 (de) | 2004-03-24 |
| JP4447459B2 (ja) | 2010-04-07 |
| US20120040363A1 (en) | 2012-02-16 |
| ATE335816T1 (de) | 2006-09-15 |
| WO2004033683A1 (de) | 2004-04-22 |
| DK1400589T3 (da) | 2006-11-27 |
| DE50207801D1 (de) | 2006-09-21 |
| JP2005538737A (ja) | 2005-12-22 |
| KR20050057152A (ko) | 2005-06-16 |
| US8062854B2 (en) | 2011-11-22 |
| CN1681925A (zh) | 2005-10-12 |
| CA2498951A1 (en) | 2004-04-22 |
| EP1400589B1 (de) | 2006-08-09 |
| US8288115B2 (en) | 2012-10-16 |
| CA2498951C (en) | 2013-04-23 |
| AU2003260392A1 (en) | 2004-05-04 |
| US20100316993A1 (en) | 2010-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8288115B2 (en) | Method for enriching a prokaryotic DNA | |
| CN113151282B (zh) | 结合新型冠状病毒(SARS-CoV-2)核衣壳蛋白的核酸适配体及其用途 | |
| ES2163865T5 (es) | Aislamiento en fase solida de acidos nucleicos. | |
| EP0389063B1 (en) | Process for isolating nucleic acid | |
| JP6533468B2 (ja) | 目的の核酸の特異的な単離方法 | |
| US20190225958A1 (en) | Method for enrichment and purification of cell-free dna from body fluid for high-throughput processing | |
| JP2008510456A (ja) | 多官能基コート化固相担体を用いる核酸の単離方法 | |
| US20120252009A1 (en) | Methods and Compositions for Enriching Either Target Polynucleotides or Non-Target Polynucleotides from a Mixture of Target and Non-Target Polynucleotides | |
| KR101443218B1 (ko) | 코스모트로픽 염을 이용한 고체 지지체에서의 ｒｎａ 정제방법 | |
| CN105132410B (zh) | 一种微生物基因组dna的提取方法 | |
| US10907146B2 (en) | Nucleic acid extraction method using solid subject | |
| US20220025354A1 (en) | Nucleic acid synthesis and purification device, use thereof, and nucleic acid synthesis and purification method | |
| WO1995004140A1 (en) | Process for isolating nucleic acid from gram positive microorganisms | |
| US20130189674A1 (en) | Methods and Compositions for Enriching Either Target Polynucleotides or Non-Target Polynucleotides from a Mixture of Target and Non-Target Polynucleotides | |
| JP2018504089A (ja) | ピペットチップおよびその使用方法 | |
| EP3194626A1 (en) | Methods and devices for detecting and identifying microorganisms | |
| ES2384571T3 (es) | Procedimiento para el enriquecimiento y/o la separación de ADN procariota mediante una proteína que se une específicamente a ADN que contiene motivos CpG no metilados | |
| CN114480690B (zh) | 金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌核酸快速检测方法及试剂盒 | |
| CN111454956B (zh) | 一种针对中华鳖虹彩病毒的核酸适配体及其构建方法和应用 | |
| KR20090036121A (ko) | 시료로부터 사전 추출 없이 거대분자를 변형시키는 방법 | |
| CN111363749A (zh) | 一种用于检测中华鳖虹彩病毒的核酸适配体及其构建方法和应用 | |
| CA3137012A1 (en) | Methods and devices for ultrasensitive direct detection of microorganisms | |
| DE102004010928B4 (de) | Protein zur Bindung prokaryonter DNA sowie Verfahren zur Trennung und Anreicherung prokaryonter DNA | |
| RU2636457C2 (ru) | ОЛИГОНУКЛЕОТИДНЫЙ БИОЧИП ДЛЯ ИДЕНТИФИКАЦИИ ГЕНЕТИЧЕСКИХ ДЕТЕРМИНАНТ РЕЗИСТЕНТНОСТИ Neisseria gonorrhoeae К АНТИМИКРОБНЫМ ПРЕПАРАТАМ, НАБОР ОЛИГОНУКЛЕОТИДОВ, ИСПОЛЬЗУЕМЫХ ДЛЯ ИММОБИЛИЗАЦИИ НА БИОЧИПЕ | |
| JP4519247B2 (ja) | 核酸の抽出精製用試薬 |